SI9200334A - High-dosed forms of collagenase for local applications - Google Patents

High-dosed forms of collagenase for local applications Download PDF

Info

Publication number
SI9200334A
SI9200334A SI19929200334A SI9200334A SI9200334A SI 9200334 A SI9200334 A SI 9200334A SI 19929200334 A SI19929200334 A SI 19929200334A SI 9200334 A SI9200334 A SI 9200334A SI 9200334 A SI9200334 A SI 9200334A
Authority
SI
Slovenia
Prior art keywords
collagenase
dextran
filler
composition according
pharmaceutical
Prior art date
Application number
SI19929200334A
Other languages
English (en)
Slovenian (sl)
Inventor
Harold Stern
David Yee
Original Assignee
Advance Biofactures Of Curacao, N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advance Biofactures Of Curacao, N.V. filed Critical Advance Biofactures Of Curacao, N.V.
Publication of SI9200334A publication Critical patent/SI9200334A/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
SI19929200334A 1991-11-20 1992-11-19 High-dosed forms of collagenase for local applications SI9200334A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79591591A 1991-11-20 1991-11-20
US07/963,995 US5393792A (en) 1991-11-20 1992-10-29 High dosage topical forms of collagenase

Publications (1)

Publication Number Publication Date
SI9200334A true SI9200334A (en) 1993-06-30

Family

ID=27121667

Family Applications (1)

Application Number Title Priority Date Filing Date
SI19929200334A SI9200334A (en) 1991-11-20 1992-11-19 High-dosed forms of collagenase for local applications

Country Status (12)

Country Link
US (3) US5393792A (fr)
EP (1) EP0543521B1 (fr)
JP (1) JPH0789871A (fr)
AT (1) ATE179612T1 (fr)
AU (1) AU654881B2 (fr)
CA (1) CA2083333C (fr)
DE (1) DE69229098T2 (fr)
ES (1) ES2130162T3 (fr)
HU (1) HUT62802A (fr)
RU (1) RU2129862C1 (fr)
SI (1) SI9200334A (fr)
YU (1) YU98792A (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6958150B2 (en) 1994-12-15 2005-10-25 Advance Biofactures Of Curacao, N.V. Reduction of adipose tissue
EP0721781B1 (fr) * 1994-12-15 2002-03-06 Advance Biofactures Of Curacao N.V. Reduction du tisse adipeux en utilisant de la collagénase
DE19503338C2 (de) * 1995-02-02 1998-07-30 Lohmann Therapie Syst Lts Arzneiform zur Abgabe von Kollagenase an Wunden und Verfahren zu ihrer Herstellung und ihre Verwendung
US5851522A (en) * 1995-06-07 1998-12-22 Trustees Of Tufts College Enhancing keratinocyte migration
US5718897A (en) * 1995-06-07 1998-02-17 Trustees Of Tufts College Enhancing keratinocyte migration and proliferation
DE19521829A1 (de) * 1995-06-16 1996-12-19 Knoll Ag Neue Verwendung von Collagenase
US6086872A (en) * 1997-03-27 2000-07-11 Advance Biofactures Of Curacao, Nv Amelioration of dupuytren's disease
WO1999062552A1 (fr) * 1998-06-03 1999-12-09 Hwa Seong Kim Medicaments a effet d'adhesion / fixation / refroidissement pour brulure et methode therapeutique permettant de soulager une cicatrice de brulure
DE19825794A1 (de) * 1998-06-10 1999-12-16 Knoll Ag Collagenase-Applikationsform
IL127209A0 (en) * 1998-11-23 1999-09-22 Bio Silk Ltd Composition and method for treatment of hypertrophic skin accumulations and their prevention
US20030198631A1 (en) * 2002-04-18 2003-10-23 Healthpoint, Ltd. Thermolysin enzymatic wound debrider
US7169405B2 (en) * 2003-08-06 2007-01-30 Warsaw Orthopedic, Inc. Methods and devices for the treatment of intervertebral discs
US20050220821A1 (en) * 2004-03-31 2005-10-06 Allergan, Inc. Pressure sore treatment
US20090010910A1 (en) * 2004-07-13 2009-01-08 Mediwound Ltd. Compositions and methods for dermatological wound healing
US20070224184A1 (en) * 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite
ITPD20050207A1 (it) 2005-07-07 2007-01-08 Fidia Farmaceutici Nuove composizioni farmaceutiche contenenti acido ialuronico e collagenas nel trattamento topico di ferite, ustioni ed ulcere
CN1935262B (zh) * 2005-09-23 2010-12-29 沈阳胜宝康生物制药有限公司 红色诺卡氏菌细胞壁骨架在制备抗人乳头瘤病毒药物的用途
US20070141106A1 (en) * 2005-10-19 2007-06-21 Bonutti Peter M Drug eluting implant
US7811560B2 (en) * 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
US8642060B2 (en) * 2006-04-24 2014-02-04 Warsaw Orthopedic, Inc. Controlled release systems and methods for osteal growth
US7879027B2 (en) * 2006-04-24 2011-02-01 Warsaw Orthopedic, Inc. Controlled release devices for fusion of osteal structures
US8642059B2 (en) * 2006-04-24 2014-02-04 Warsaw Orthopedic, Inc. Controlled release systems and methods for intervertebral discs
US7771414B2 (en) * 2006-04-24 2010-08-10 Warsaw Orthopedic, Inc. Controlled release devices for therapeutic treatments of spinal discs
US8323642B2 (en) * 2006-12-13 2012-12-04 Depuy Mitek, Inc. Tissue fusion method using collagenase for repair of soft tissue
US10071143B1 (en) 2007-05-03 2018-09-11 The Research Foundation For The State University Of New York Methods for non-surgical treatment of carpal tunnel syndrome
US20100159564A1 (en) * 2007-11-30 2010-06-24 Dwulet Francis E Protease resistant recombinant bacterial collagenases
WO2010050980A1 (fr) * 2008-10-31 2010-05-06 Laboratory Skin Care, Inc. Formulations topiques comprenant des particules d'hydroxyapatite pour la stimulation et le maintien des fibres de collagène
US9694100B2 (en) 2009-12-08 2017-07-04 Smith & Nephew, Inc. Enzymatic wound debriding compositions with enhanced enzymatic activity
US10119131B2 (en) 2011-03-16 2018-11-06 Biospecifics Technologies Corp. Compositions and methods for producing clostridial collagenases
ES2968836T3 (es) 2012-01-12 2024-05-14 Endo Global Ventures Enzima del clostridium histolyticum
WO2013125276A1 (fr) * 2012-02-21 2013-08-29 株式会社 東芝 Dispositif de tomodensitométrie, dispositif d'affichage d'images et procédé d'affichage d'images
US9636385B2 (en) 2012-10-24 2017-05-02 The Research Foundation For The State University Of New York Use of collagenase to treat glaucoma
CA3012299C (fr) 2016-01-31 2022-05-31 Mediwound Ltd. Composition de debridement destinee au traitement des plaies
EP3445389B1 (fr) 2016-04-18 2022-10-26 Mediwound Ltd Formulations pour le débridement des plaies chroniques
KR20230003601A (ko) 2017-03-01 2023-01-06 엔도 벤쳐즈 리미티드 셀룰라이트를 평가하고 치료하기 위한 장치 및 방법
KR102642381B1 (ko) 2017-03-28 2024-02-28 엔도 벤쳐즈 리미티드 개선된 콜라게나제 생성 방법
US20220362327A1 (en) * 2021-05-13 2022-11-17 Nasser Diab Compositions and methods for wound healing

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH437641A (de) * 1961-05-30 1967-06-15 Bernburg Serum Werk Veb Verfahren zur Herstellung von fettfreien Salbengrundlagen
US3392161A (en) * 1964-10-15 1968-07-09 Gen Tire & Rubber Co Gel-free halogenated polybutadiene rubber-resins
US3705083A (en) * 1966-07-08 1972-12-05 Agricultural Biolog Corp Process for producing collagenase
US3792161A (en) * 1970-05-18 1974-02-12 Research Corp Burn ointment comprising silver sulfadiazine and collagenase
US3678158A (en) * 1971-05-11 1972-07-18 Worthington Bio Chem Corp Treatment of herniated intervertebral discs of mammals
US4089333A (en) * 1972-10-28 1978-05-16 Nippi, Incorporated Method of treating a wound or burn
US3876501A (en) * 1973-05-17 1975-04-08 Baxter Laboratories Inc Binding enzymes to activated water-soluble carbohydrates
US4174389A (en) * 1977-05-13 1979-11-13 Cope Louise A Ophthalmic use of collagenase
US4338300A (en) * 1981-02-05 1982-07-06 The Regents Of The University Of California Use of purified clostridial collangenase in the treatment of Peyronie's disease
US4485088A (en) * 1982-03-26 1984-11-27 Bio-Products, Inc. Method of treatment of fibrotic lesions by topical administration of lathyrogenic drugs
US4524065A (en) * 1983-08-04 1985-06-18 Bio-Specifics N.V. Method for the prevention and treatment of scars with enzymes
GB2150833B (en) * 1983-12-08 1987-04-15 Ceskoslovenska Akademie Ved Proteolytic wounds dressing
NZ226171A (en) * 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
US5173295A (en) * 1990-10-05 1992-12-22 Advance Biofactures Of Curacao, N.V. Method of enhancing the regeneration of injured nerves and adhesive pharamaceutical formulation therefor

Also Published As

Publication number Publication date
EP0543521A3 (en) 1993-07-28
JPH0789871A (ja) 1995-04-04
DE69229098D1 (de) 1999-06-10
AU2853592A (en) 1993-05-27
CA2083333A1 (fr) 1993-05-21
RU2129862C1 (ru) 1999-05-10
HU9203623D0 (en) 1993-01-28
US5393792A (en) 1995-02-28
AU654881B2 (en) 1994-11-24
HUT62802A (en) 1993-06-28
DE69229098T2 (de) 1999-09-09
EP0543521A2 (fr) 1993-05-26
ATE179612T1 (de) 1999-05-15
ES2130162T3 (es) 1999-07-01
EP0543521B1 (fr) 1999-05-06
YU98792A (sh) 1995-12-04
CA2083333C (fr) 2000-05-30
US5514370A (en) 1996-05-07
US5422103A (en) 1995-06-06

Similar Documents

Publication Publication Date Title
SI9200334A (en) High-dosed forms of collagenase for local applications
US4401651A (en) Wound-healing compositions containing povidone-iodine
US5563153A (en) Sterile topical anesthetic gel
US6238692B1 (en) Medical dressing for application and maintenance of medication on body tissue
EP2489338B1 (fr) Pansement de plaie sec et système de délivrance de médicament
RU2718554C1 (ru) Термостабильная композиция, обладающая антивирусной и антибактериальной активностью и ее использование
HU226710B1 (en) Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the upper respiratory tract and/or the ear
EP1830895A2 (fr) Agents permettant de controler des fluides biologiques et leurs procedes d'utilisation
RU2211022C2 (ru) Способ лечения поверхностных афтозных язв на слизистой оболочке полости рта и местное лекарственное средство для лечения язв слизистой оболочки рта
AU4292293A (en) Bioadhesive solid mineral oil emulsion
KR20120022930A (ko) 은 설파디아진 및 키토산을 사용하여 제조한 약용 크림 및 이의 제조 방법
ES2546748T3 (es) Formulaciones oftalmológicas
EP1773379A2 (fr) Compositions et methodes de cicatrisation pour lesions dermatologiques
GB2048070A (en) Medication for Open Wounds
US5707972A (en) Hydrophilic polysaccharide-based pharmaceutical perparation for external use
US3079299A (en) Self-propelling medicinal ointment composition containing polyethylene and method ofapplication
US8252335B2 (en) Healing powder and method of use thereof
US20180116986A1 (en) Composition of novel powder formulations of tranexamic acid
JP3767831B2 (ja) ヘリコバクター・ピロリ除菌用組成物
JP2983335B2 (ja) ホスホマイシン及びその医薬的に許容可能な塩の局所瘢痕形成剤としての使用
RU2146136C1 (ru) Антисептическое средство "катацел"
RU2536266C2 (ru) Крем медицинского назначения, изготовленный с использованием фрамицетина сульфата и хитозана, и способ его изготовления
Nelson The prevention of infection in total joint replacement surgery
WO2015098864A4 (fr) Agent de formation de gel contenant un sulfonamide et un chitosane et se présentant sous forme de dosage en poudre
US10517989B1 (en) Enhanced medical dressing apparatus, system, and method